Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Aug. 13, 1999

Viron Therapeutics awarded US patent for use of viral proteins as antiinflammatory agents

Aug. 6, 1999

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

Aug. 5, 1999

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Aug. 3, 1999

Mutual recognition granted to Agrippal; vaccine to be marketed throughout Europe

Aug. 2, 1999

Aviron and Medeva extend FluMist collaboration

Aug. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...